May 31, 2024 — Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part of Johnson & Johnson and will operate as a business unit within Johnson & ...
Peripheral Artery Disease (PAD)
This channel includes news, interventions, and new technology innovations for peripheral artery diease, PAD and critical limb ischemia.
July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...
May 31, 2024 — Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part ...
May 30, 2024 — Biotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC ...
May 16, 2024 — A recent publication in the American Heart Association Circulation highlights a comprehensive ...
May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...
May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...
April 24, 2024 — Expanse ICE announced today the ICE Aspiration System has received 510(k) clearance from the U.S. Food ...
April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...
April 11, 2024 — One-year success rates from angioplasty procedures to open clogged arteries in the legs were ...
April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...
March 27, 2024 — Elixir Medical has announced it has been granted Breakthrough Device Designation by the U.S. Food and ...
March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...
February 14, 2024 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that ...
February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...
January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...